Yuri Deigin is a Toronto-based drug developer specializing in Alzheimer's and CNS gene therapies. He co-founded DRASTIC, contributing to innovative approaches in neurodegenerative disease research and longevity. As a vitalist and longevity maximalist, Deigin focuses on advancing gene therapies to extend healthspan and combat age-related disorders.

‌